Rentschler Biopharma SE
Thank you for visiting our virtual exhibit space.
About Rentschler Biopharma SE
At Rentschler Biopharma, we enable your product’s success by translating medical research into outstanding biopharmaceuticals. We live your product - from concept to market.
Founded in 1927, we are a family-owned company with almost 50 years of proven scientific expertise in biotechnology. In 1997, we pioneered biopharma outsourcing and were one of the world’s first CDMOs.
From our headquarters in Laupheim, Germany, and our site in Milford, MA, USA, we are your outsourcing partner of choice for bioprocess development and cGMP manufacturing. We offer you best-in-class formulation development, considered at every step of the biopharmaceutical process, in our strategic alliance with LEUKOCARE AG.
Our strength lies in our experience with highly complex molecules. Fusion proteins, recombinant enzymes, monoclonal and multi-specific antibodies, are among the 100 different formats that we have handled. Our track record of 300 molecules for 150 clients worldwide, translates to unrivalled experience along the entire biopharmaceutical value chain.
Our attention is firmly focused on your needs. We guarantee best-fit solutions for your product by balancing timeline requirements with a comprehensive manufacturability assessment, and always putting quality first. This commitment is reflected in our outstanding regulatory track record, as well as our exceptional client-oriented project management and regulatory support.
Dr. Daniel Mattle
Director Business Development Europe
Switzerland, Austria, Eastern Europe, Scandinavia, Middle East, Japan
Phone: +49 7392 701-453
DR. PATRICK MEYER
Director Business Development
DACH, BeNeLux, UK, Ireland, Australia/New Zealand, South Africa, South America
Phone: +49 7392 701-566